Related by context. Frequent words. (Click for all words.) 51 WW Grainger NYSE GWW 50 Cimarex Energy NYSE XEC 49 True MACD 48 SABCS 47 #th Annual Interscience 47 Japan Index Fd 45 Bristol Myers NYSE BMY 44 P Dep Receipts 44 #.#points [005] 43 ongoing Phase 1b 43 Losers outpaced gainers 43 Significant assay 43 Clinical Trial Results 42 RTTNews Stocks 42 BVSP 42 Acme Packet NASDAQ APKT 42 MILA#PUS 41 DX Y 41 Preliminary 41 Unaudited Fourth Quarter 41 Earnings Per Diluted 41 fasting plasma glucose FPG 41 Unofficial returns 41 Results 41 Preliminary Assessment Study 41 PROSTVAC TM 40 blue chip Ipsa 40 Toxicological 40 euro Eur Usd 40 Webcast Scheduled 40 http:/www.ap-gfkpoll.com 39 weaker reversing 39 AVADO 39 Stocks barely budged 39 Winning Notification 39 Guides FY# 39 USDJPY traded 39 GAAP Adj 39 Half Yearly Report 39 NEO3 39 Pharmacokinetic 39 NEW YORK Stocks fluctuated 39 aussie Aud Usd 39 Preliminary Third Quarter 39 TOKYO CBS.MW Japanese 39 Pivotal Phase III 39 Preliminary metallurgical 39 CONSOLIDATED RESULTS 38 Ibovespa index 38 Comp Store 38 cad Usd Cad 38 phase 2a 38 Confirmatory 38 Phase Ib clinical 38 Markit Economics showed 38 Preliminary Results 38 yen Usd Jpy 38 Guidance Guidance 38 National Epidemiologic Survey 38 Secondary endpoints 38 Cognitive Function 38 #.# RUR EUR 38 Guidance Quick Facts 38 Phase IIB 38 Improves Survival 38 Drug Candidate 37 pound Gbp Usd 37 Unaudited Third Quarter 37 Fiscal Second Quarter 37 VIENNA Austria Oil 37 Phase IIa clinical 37 #mg/dL [001] 37 Immunogenicity 37 Audiotapes 37 driver Ricardo Zonta 37 border controllers SBCs 37 Q2 FY# [001] 37 story.className = story.className.replace read 37 fractionally lower 37 Phase Ib II 37 Significant intercepts 37 NLX P# 37 Drill intersections 37 NASDAQ QQQQ 37 Stocks fluctuated 37 St. Maarten Charter 37 FY# Guidance 37 NFL.com wire 37 iniparib 37 Shareholder Letter 37 PROPEL trial 37 Speaker Jassem 37 Period Ending 37 Common Share Offering 37 SPIRIT III 37 Backs FY# EPS 37 Radiographs 37 Second Quarter Ended 37 nonclinical studies 37 2nd Quarter Results 37 Dividend Announcement